Serum Institute puts India trials of AstraZeneca's COVID-19 vaccine on hold


FE Team | Published: September 10, 2020 16:56:41 | Updated: September 16, 2020 21:05:23


Serum Institute puts India trials of AstraZeneca's COVID-19 vaccine on hold

Serum Institute of India has put trials of AstraZeneca’s COVID-19 vaccine candidate on hold until the British drugmaker restarts the trials, Serum said on Thursday.

“We are reviewing the situation and pausing India trials,” Serum said in a brief statement, reports Reuters.

AstraZeneca said on Tuesday it had paused trials of its experimental coronavirus vaccine because of an unexplained illness in a study participant, but its partner Serum had at the time said its trials in India were still ongoing.

Share if you like